中文 | English
Return
Total: 371 , 1/38
Show Home Prev Next End page: GO
Author:(Ling-yun ZHAO)

1.Mechanism of transcription factor ZEB1 in the proliferation, migration, and invasion of lung adenocarcinoma cells

Yun ZHAO ; Beibei MA ; Huaxue XING ; Shaofeng HUANG ; Zhongwei ZHANG ; Bo LING

Acta Universitatis Medicinalis Anhui 2026;61(3):470-479

2.Analysis of influencing factors of major adverse cardio-cerebrovascular events after drug-eluting stenting in patients with coronary artery disease

Zhao-yun MENG ; Yan-qun ZHANG ; Xiu-ling WANG

Chinese Journal of cardiovascular Rehabilitation Medicine 2025;34(2):135-139

3.The synergistic effect and mechanism verification of effective components of Biejia-Ezhu against triple-negative breast cancer based on network pharmacology and component compatibility theory

Dou-dou FENG ; Xiao-shan LUO ; Yan-yun MENG ; Jing-zhe ZHAO ; Jiu-long ZHU ; Ya-zhen HUANG ; Qing XIE ; Xiang-Li LING ; Su XIE

Chinese Pharmacological Bulletin 2025;41(5):950-959

4.Interpretation of"Standard for infection prevention and control in hemodialysis department(center)"WS/T854-2025

Yanyan WU ; Min DENG ; Huixue JIA ; Anhua WU ; Li ZUO ; Yunxi LIU ; Jiancheng ZHAO ; Jiansheng LIANG ; Yun YANG ; Ling LIN

Chinese Journal of Nosocomiology 2025;35(20):3045-3048

5.Analysis of influencing factors of major adverse cardio-cerebrovascular events after drug-eluting stenting in patients with coronary artery disease

Zhao-yun MENG ; Yan-qun ZHANG ; Xiu-ling WANG

Chinese Journal of cardiovascular Rehabilitation Medicine 2025;34(2):135-139

6.Agitation of TGR5 by INT-777 protected hypoxic-ischemic encephalopathy in neonatal rats

Rong-jie LIU ; Qin CHEN ; Ying XIONG ; Zhao-yun WANG ; Chang-ling CHEN ; Qin ZHANG ; Mao-qiong CHEN ; Zhan-hui FENG ; Lan YE

Chinese Pharmacological Bulletin 2025;41(6):1085-1090

7.Efficacy and Safety of Polatuzumab Vedotin Combined with Chemotherapy in the Treatment of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Ke-Ting JIN ; Jin-Dan XIA ; Chu-Yun QIAN ; Qian ZHANG ; Qian JIANG ; Song-Di CHEN ; Wei-Ze ZHANG ; Lu-Ling MAO ; Yi ZHAO

Journal of Experimental Hematology 2025;33(6):1617-1622

8.Oroxylin A induces apoptosis in Ishikawa cell line of endometrial cancer via PI3K/AKT signaling pathway

Huan-huan ZHAO ; Yu-qian JIAO ; Ruo-qi QIAO ; Xue BAI ; Na WANG ; Yun-jie TIAN ; Wen-ling FAN ; Li LI ; Su-wen SU ; Yan FU ; Hui ZHANG ; Hong-fang YANG

Chinese Pharmacological Bulletin 2025;41(3):555-560

9.Interpretation of"Standard for infection prevention and control in hemodialysis department(center)"WS/T854-2025

Yanyan WU ; Min DENG ; Huixue JIA ; Anhua WU ; Li ZUO ; Yunxi LIU ; Jiancheng ZHAO ; Jiansheng LIANG ; Yun YANG ; Ling LIN

Chinese Journal of Nosocomiology 2025;35(20):3045-3048

10.Chinese experts' consensus on principles of preoperative hair removal

Yiping MAO ; Jun ZHENG ; Lei LI ; Deyan YANG ; Bing ZHANG ; Lei YANG ; Wang JIA ; Peng KANG ; Hui JIAO ; Yun YANG ; Qi QI ; Shiqing FENG ; Xiao LONG ; Yuewei ZHANG ; Xiaohui WANG ; Lize WANG ; Yuan WEI ; Jichao ZHOU ; Minghui MAO ; Pengju XIN ; Hongyu TAN ; Dahong ZHANG ; Lianxin LIU ; Lei TAO ; Xietong WANG ; Xiaoning YUAN ; Mang CAI ; Li MU ; Fang DU ; Rongzhu CHEN ; Fengmao ZHAO ; Jiuzuo HUANG ; Mingzi ZHANG ; Jie ZHANG ; Baoguo WANG ; Kun WANG ; Fang LUO ; Jinhua ZHANG ; Nong HE ; Ling LYU ; Zhiyong ZONG

Chinese Journal of Nosocomiology 2025;35(10):1441-1449

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 371 , 1/38 Show Home Prev Next End page: GO